Newsroom | 12801 results
Sorted by: Latest
-
Samenvatting: Philips en Imricor lanceren een MR-laboratoriumoplossing voor hartingrepen en breiden daarmee hun langdurige samenwerking uit
AMSTERDAM--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), een wereldwijde marktleider op het gebied van gezondheidstechnologie, en Imricor Medical Systems (ASX: IMR), een pionier en toonaangevende ontwikkelaar van MR-compatibele producten voor interventionele MR-procedures, hebben vandaag een nieuwe laboratoriumoplossing voor interventionele MR (iMR) aangekondigd voor de 1,5T MR-scanners van Philips. Deze eerste commercieel beschikbare configuratie combineert het 1,5T MRI-platform van P...
-
Resumen: Philips e Imricor presentan una solución de RM intervencionista cardíaca y amplían su colaboración
ÁMSTERDAM--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), líder mundial en tecnología sanitaria, e Imricor Medical Systems (ASX: IMR), empresa pionera y líder mundial en el desarrollo de productos compatibles con RM para procedimientos intervencionistas guiados por RM, han anunciado hoy una nueva solución de RM intervencionista (iMR) para los equipos de RM de 1,5 T de Philips. La primera configuración disponible comercialmente combina la plataforma de RM de 1,5 T de Philips con la carte...
-
Philips and Imricor Launch Cardiac Interventional MR Lab Solution, Expanding Longstanding Collaboration
AMSTERDAM--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Imricor Medical Systems (ASX: IMR), a pioneer and world-leading developer of MR-compatible products for interventional MR procedures, today announced a new Interventional MR (iMR) lab solution for Philips 1.5T MR. The first commercially available configuration* combines Philips’ 1.5T MRI platform and Imricor's portfolio of iMR systems and consumables, enabling an MR-guided workflow for ca...
-
American Medical Society for Sports Medicine and OpenEvidence Announce Partnership to Bring AI-Powered Sports Medicine Resources to Clinicians and Patients
MIAMI & LEAWOOD, Kan.--(BUSINESS WIRE)--The American Medical Society for Sports Medicine (AMSSM) and OpenEvidence today announced a partnership that will focus on co-developing AI-powered educational resources on sports medicine for both patients and clinicians. This exclusive collaboration brings the expertise of AMSSM’s sports medicine physicians to OpenEvidence, the leading AI-powered clinical decision support platform, and will build on the AMSSM’s robust foundation of educational materials....
-
Vascular Technology, Incorporated Appoints David Pierce to Board of Directors
NASHUA, N.H.--(BUSINESS WIRE)--Vascular Technology, Incorporated (“VTI” or the “Company”), a medical device company specializing in the development, manufacturing and sale of surgical devices, today announced the appointment of David Pierce to its Board of Directors. Pierce brings more than three decades of experience leading innovation, transformation and sustainable growth across global medical device and healthcare technology markets. He currently serves on the boards of Neuraptive Therapeut...
-
Protaryx Medical Announces First U.S. Commercial Cases With Its Transseptal Puncture Device
BALTIMORE--(BUSINESS WIRE)--Protaryx Medical, an innovative medical device company developing differentiated access solutions for minimally invasive left-heart procedures, today announced the successful completion of the first U.S. commercial cases using its FDA-cleared Protaryx Transseptal Puncture Device. The procedures were performed at UC Davis Health in Sacramento, California, by interventional cardiologist Gagan D. Singh, M.D. The first two commercial cases were performed during left atri...
-
Covalon Reports Fiscal 2026 Third Quarter Results
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2026 third quarter results for the period ended June 30, 2026. Full financial statements and management’s discussion and analysis are available on the Company’s profile at www.sedarplus.ca. Brent Ashton, Covalon’s Chief Executive Officer, commented, “Covalon’s third quarter of fiscal 2026 delivered outstandi...
-
Integrated Dermatology Welcomes Stefanie Indellicati, PA-C to West Palm Beach Practice
BOCA RATON, Fla.--(BUSINESS WIRE)--Stefanie Indellicati, PA-C, joins Integrated Dermatology of West Palm Beach, bringing ER, primary care and cosmetic dermatology expertise to patients....
-
CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare Conference
LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced its participation in the Wells Fargo 21st Annual Healthcare Conference, which is being held September 8-10, 2026 at the Encore Boston Harbor in Everett, MA. Management will participate in a fireside chat on Wednesday, September 9th at 1:30 p.m. Eastern Time. A live audio webcast of the fireside chat will be accessible under the “Events” section of the company’s investor relations website: https://www.conmed.com/en/inv...
-
Dr. Andrew Patel and Oath Surgical Bring Sleep Apnea Implant to Oregon in a First for Pacific Northwest Outpatient Surgery
SAN FRANCISCO--(BUSINESS WIRE)--Oath Surgical today announced that Dr. Andrew Patel has performed the first of its kind implant procedure in Oregon and the first in the Pacific Northwest to take place in an ambulatory surgery center (ASC) setting. The milestone expands access to an innovative treatment option in a state where an estimated 1.1 million residents, or 31% of the population, have mild to severe obstructive sleep apnea (OSA), including approximately 165,000 people in Portland. Genio,...